Molmed

MolMed operates as a biotechnology firm that specializes in the exploration, creation, manufacturing, and clinical substantiation of genetic and cellular treatments targeted at battling cancer and rare ailments. Leveraging more than two decades of expertise and knowledge, MolMed has emerged as a prominent participant in the Cell & Gene sphere, proficient in overseeing all phases of research leading to the commercialization of advanced genetic and cellular therapies.